{"transactions":[{"id":677705,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:06:57.000Z","date":"2026-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":25729,"price":0.672,"value":17289.888,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 3 and Form 4s filed with the U.S. Securities and Exchange Commission on September 3, 2024, March 24, 2025 and April 8, 2026."}],"balance_after":1480823,"source":{"system":"sec-edgar","filing":"0001193125-26-363767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526363767/ownership.xml","form_type":"4"}},{"id":677987,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:05:24.000Z","date":"2026-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":28195,"price":0.672,"value":18947.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024, March 24, 2025 and April 8, 2026 respectively."}],"balance_after":2534859,"source":{"system":"sec-edgar","filing":"0001193125-26-363762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312526363762/ownership.xml","form_type":"4"}},{"id":677704,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-24T21:04:56.000Z","date":"2026-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":97627,"price":0.672,"value":65605.344,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024, March 24, 2025 and April 8, 2026 respectively."}],"balance_after":6137704,"source":{"system":"sec-edgar","filing":"0001193125-26-363758","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526363758/ownership.xml","form_type":"4"}},{"id":697628,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-04T22:01:02.000Z","date":"2026-08-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":362625,"price":0.868,"value":314758.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on August 1, 2025, which grant was originally reported on a Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2025."}],"balance_after":6235331,"source":{"system":"sec-edgar","filing":"0001193125-26-333225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526333225/ownership.xml","form_type":"4"}},{"id":703171,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-27T23:28:40.000Z","date":"2026-07-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":202476,"price":0.895,"value":181216.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on August 1, 2025, which grant was originally reported on a Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares of common stock acquired by the reporting person on May 29, 2026 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":2563054,"source":{"system":"sec-edgar","filing":"0001193125-26-318442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312526318442/ownership.xml","form_type":"4"}},{"id":729455,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-23T21:45:22.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":263884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":263884,"derivative":{"exercise_price":0.8297,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":263884},"source":{"system":"sec-edgar","filing":"0001193125-26-279834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279834/ownership.xml","form_type":"4"}},{"id":729454,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:45:22.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":99116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":344456,"source":{"system":"sec-edgar","filing":"0001193125-26-279834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279834/ownership.xml","form_type":"4"}},{"id":729453,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:45:02.000Z","date":"2026-06-20","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), 40% of which will vest on June 20, 2027, and the remaining 60% of which will vest on June 20, 2028 subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":1506552,"source":{"system":"sec-edgar","filing":"0001193125-26-279833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279833/ownership.xml","form_type":"4"}},{"id":729452,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-23T21:43:41.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":175923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":175923,"derivative":{"exercise_price":0.8297,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":175923},"source":{"system":"sec-edgar","filing":"0001193125-26-279830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279830/ownership.xml","form_type":"4"}},{"id":729451,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:43:41.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":99116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":309978,"source":{"system":"sec-edgar","filing":"0001193125-26-279830","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279830/ownership.xml","form_type":"4"}},{"id":729450,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36006,"kind":"person","name":"Casdin Eli","position":1,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-23T21:41:32.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":175923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":175923,"derivative":{"exercise_price":0.8297,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":175923},"source":{"system":"sec-edgar","filing":"0001193125-26-279828","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279828/ownership.xml","form_type":"4"}},{"id":729449,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36006,"kind":"person","name":"Casdin Eli","position":1,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:41:32.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":99116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":3053169,"source":{"system":"sec-edgar","filing":"0001193125-26-279828","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279828/ownership.xml","form_type":"4"}},{"id":729448,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-23T21:41:00.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":175923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":175923,"derivative":{"exercise_price":0.8297,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":175923},"source":{"system":"sec-edgar","filing":"0001193125-26-279827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279827/ownership.xml","form_type":"4"}},{"id":729447,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:41:00.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":99116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":475702,"source":{"system":"sec-edgar","filing":"0001193125-26-279827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279827/ownership.xml","form_type":"4"}},{"id":729446,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36079,"kind":"person","name":"ELOI FENEL M","position":1,"cik":"0001237190","reported_name":"ELOI FENEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-23T21:39:21.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":175923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":175923,"derivative":{"exercise_price":0.8297,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":175923},"source":{"system":"sec-edgar","filing":"0001193125-26-279824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279824/ownership.xml","form_type":"4"}},{"id":729445,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36079,"kind":"person","name":"ELOI FENEL M","position":1,"cik":"0001237190","reported_name":"ELOI FENEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:39:21.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":99116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":335299,"source":{"system":"sec-edgar","filing":"0001193125-26-279824","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279824/ownership.xml","form_type":"4"}},{"id":729444,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":19440,"kind":"person","name":"HIBBS KATHY L","position":1,"cik":"0001267487","reported_name":"HIBBS KATHY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-23T21:39:19.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":175923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":175923,"derivative":{"exercise_price":0.8297,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":175923},"source":{"system":"sec-edgar","filing":"0001193125-26-279823","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279823/ownership.xml","form_type":"4"}},{"id":729443,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":19440,"kind":"person","name":"HIBBS KATHY L","position":1,"cik":"0001267487","reported_name":"HIBBS KATHY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:39:19.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":99116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":236836,"source":{"system":"sec-edgar","filing":"0001193125-26-279823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279823/ownership.xml","form_type":"4"}},{"id":766779,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-22T21:20:05.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":18871,"price":1,"value":18871.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024, March 24, 2025 and April 8, 2026, respectively."}],"balance_after":2760530,"source":{"system":"sec-edgar","filing":"0001193125-26-237189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312526237189/ownership.xml","form_type":"4"}},{"id":766477,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-05-22T21:17:30.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":25729,"price":1,"value":25729.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 3 and Form 4s filed with the U.S. Securities and Exchange Commission on September 3, 2024,  March 24, 2025 and April 8, 2026, respectively."}],"balance_after":1006552,"source":{"system":"sec-edgar","filing":"0001193125-26-237182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526237182/ownership.xml","form_type":"4"}},{"id":766464,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-05-22T21:17:22.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":97626,"price":1,"value":97626.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024, March 24, 2025 and April 8, 2026, respectively."}],"balance_after":6597956,"source":{"system":"sec-edgar","filing":"0001193125-26-237181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526237181/ownership.xml","form_type":"4"}},{"id":812812,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-04-09T01:55:05.000Z","date":"2026-04-06","kind":"exercise","planned":false,"acquired":false,"shares":196513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":196513},"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":812811,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2026-04-09T01:55:05.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":2345340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":2345340,"derivative":{"exercise_price":0.9846,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":2345340},"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":812810,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:05.000Z","date":"2026-04-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":95014,"price":0.908,"value":86272.712,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of RSUs granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022."}],"balance_after":6695582,"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":812809,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:05.000Z","date":"2026-04-06","kind":"exercise","planned":false,"acquired":true,"shares":196513,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6790596,"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":812808,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:05.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":1042373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":6594083,"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":812807,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-04-09T01:55:04.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":612240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":612240,"derivative":{"exercise_price":0.9846,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":612240},"source":{"system":"sec-edgar","filing":"0001193125-26-148614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148614/ownership.xml","form_type":"4"}},{"id":812806,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:04.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":272107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":1032281,"source":{"system":"sec-edgar","filing":"0001193125-26-148614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148614/ownership.xml","form_type":"4"}},{"id":812903,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-09T01:55:03.000Z","date":"2026-04-06","kind":"exercise","planned":false,"acquired":false,"shares":70183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":70183},"source":{"system":"sec-edgar","filing":"0001193125-26-148613","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312526148613/ownership.xml","form_type":"4"}},{"id":812902,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-04-09T01:55:03.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":727140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":727140,"derivative":{"exercise_price":0.9846,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":727140},"source":{"system":"sec-edgar","filing":"0001193125-26-148613","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312526148613/ownership.xml","form_type":"4"}},{"id":812901,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:03.000Z","date":"2026-04-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":21301,"price":0.908,"value":19341.308,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022."}],"balance_after":2779401,"source":{"system":"sec-edgar","filing":"0001193125-26-148613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312526148613/ownership.xml","form_type":"4"}},{"id":812900,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:03.000Z","date":"2026-04-06","kind":"exercise","planned":false,"acquired":true,"shares":70183,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2800702,"source":{"system":"sec-edgar","filing":"0001193125-26-148613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312526148613/ownership.xml","form_type":"4"}},{"id":812899,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:03.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":323173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":2730519,"source":{"system":"sec-edgar","filing":"0001193125-26-148613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312526148613/ownership.xml","form_type":"4"}},{"id":874917,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36006,"kind":"person","name":"Casdin Eli","position":1,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T01:02:27.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":52991,"price":1.17,"value":61999.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 25% on the last day of the last month of each fiscal quarter of 2026, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $62,000 in cash compensation for services as a board member."}],"balance_after":2954053,"source":{"system":"sec-edgar","filing":"0001193125-26-086197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526086197/ownership.xml","form_type":"4"}},{"id":874916,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T00:32:35.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":57264,"price":1.17,"value":66998.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 25% on the last day of the last month of each fiscal quarter of 2026, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $67,000 in cash compensation for services as a board member."}],"balance_after":376586,"source":{"system":"sec-edgar","filing":"0001193125-26-086158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526086158/ownership.xml","form_type":"4"}},{"id":874915,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T00:31:32.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":51282,"price":1.17,"value":59999.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 25% on the last day of the last month of each fiscal quarter of 2026, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $60,000 in cash compensation for certain services as a board member."}],"balance_after":245340,"source":{"system":"sec-edgar","filing":"0001193125-26-086154","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526086154/ownership.xml","form_type":"4"}},{"id":885549,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-24T22:45:31.000Z","date":"2026-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":66127,"price":1.15,"value":76046.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively."}],"balance_after":5551710,"source":{"system":"sec-edgar","filing":"0001193125-26-067641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526067641/ownership.xml","form_type":"4"}},{"id":885548,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-02-24T22:44:23.000Z","date":"2026-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":19661,"price":1.15,"value":22610.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 3 and Form 4 filed with the U.S. Securities and Exchange Commission on September 3, 2024 and March 24, 2025, respectively."}],"balance_after":760174,"source":{"system":"sec-edgar","filing":"0001193125-26-067638","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526067638/ownership.xml","form_type":"4"}},{"id":886278,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-24T22:44:05.000Z","date":"2026-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":12740,"price":1.15,"value":14651.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares of common stock acquired by the reporting person on November 28, 2025 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":2407346,"source":{"system":"sec-edgar","filing":"0001193125-26-067636","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312526067636/ownership.xml","form_type":"4"}},{"id":980545,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":5,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-12-05T01:59:44.000Z","date":"2025-12-04","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":1.4468,"value":217020.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.4331 to $1.4588. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":72100000,"source":{"system":"sec-edgar","filing":"0000919574-25-007243","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007243/ownership.xml","form_type":"4"}},{"id":980544,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":5,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-12-05T01:59:44.000Z","date":"2025-12-03","kind":"purchase","planned":false,"acquired":true,"shares":75000,"price":1.4405,"value":108037.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.4403 to $1.4406. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":71950000,"source":{"system":"sec-edgar","filing":"0000919574-25-007243","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007243/ownership.xml","form_type":"4"}},{"id":980543,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":5,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-12-05T01:59:44.000Z","date":"2025-12-02","kind":"purchase","planned":false,"acquired":true,"shares":125000,"price":1.4201,"value":177512.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.4050 to $1.4351. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":71875000,"source":{"system":"sec-edgar","filing":"0000919574-25-007243","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007243/ownership.xml","form_type":"4"}},{"id":987500,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":2,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":3,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":4,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":5,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":7,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":8,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-26T21:58:37.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":7550000,"price":1.3031,"value":9838405.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.30 to $1.3843. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":71750000,"source":{"system":"sec-edgar","filing":"0000919574-25-007187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007187/ownership.xml","form_type":"4"}},{"id":987499,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":2,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":3,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":4,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":5,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":7,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":8,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-26T21:58:37.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":1.4325,"value":214875.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.4290 to $1.4396. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":64200000,"source":{"system":"sec-edgar","filing":"0000919574-25-007187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007187/ownership.xml","form_type":"4"}},{"id":990459,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-24T22:05:15.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":63529,"price":1.28,"value":81317.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively."}],"balance_after":5617837,"source":{"system":"sec-edgar","filing":"0001193125-25-293843","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312525293843/ownership.xml","form_type":"4"}},{"id":990625,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-24T22:04:32.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":12739,"price":1.28,"value":16305.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively."}],"balance_after":2415086,"source":{"system":"sec-edgar","filing":"0001193125-25-293842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000119312525293842/ownership.xml","form_type":"4"}},{"id":990452,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-11-24T22:03:50.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":19661,"price":1.28,"value":25166.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 3 and Form 4 filed with the U.S. Securities and Exchange Commission on September 3, 2024 and March 24, 2025, respectively."}],"balance_after":779835,"source":{"system":"sec-edgar","filing":"0001193125-25-293841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312525293841/ownership.xml","form_type":"4"}},{"id":992817,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-21T00:45:54.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":450000,"price":1.3028,"value":586260.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2788 to $1.3500 . The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":64050000,"source":{"system":"sec-edgar","filing":"0000919574-25-007124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007124/ownership.xml","form_type":"4"}},{"id":992816,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-21T00:45:54.000Z","date":"2025-11-19","kind":"purchase","planned":false,"acquired":true,"shares":350000,"price":1.2826,"value":448910.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2758 to $1.2870. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":63600000,"source":{"system":"sec-edgar","filing":"0000919574-25-007124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007124/ownership.xml","form_type":"4"}},{"id":992815,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-21T00:45:54.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":275000,"price":1.2342,"value":339405.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2247 to $1.2421. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":63250000,"source":{"system":"sec-edgar","filing":"0000919574-25-007124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007124/ownership.xml","form_type":"4"}},{"id":998108,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-17T23:58:04.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":225000,"price":1.2248,"value":275580.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2175 to $1.2299. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":62975000,"source":{"system":"sec-edgar","filing":"0000919574-25-007087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007087/ownership.xml","form_type":"4"}},{"id":998107,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-17T23:58:04.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":250000,"price":1.2392,"value":309800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2364 to $1.2434. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":62750000,"source":{"system":"sec-edgar","filing":"0000919574-25-007087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007087/ownership.xml","form_type":"4"}},{"id":998106,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-17T23:58:04.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":450000,"price":1.2031,"value":541395.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.1978 to $1.2098. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":62500000,"source":{"system":"sec-edgar","filing":"0000919574-25-007087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425007087/ownership.xml","form_type":"4"}},{"id":1002460,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":3,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":5,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":8,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-13T00:46:08.000Z","date":"2025-11-12","kind":"purchase","planned":false,"acquired":true,"shares":375000,"price":1.1889,"value":445837.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.1865 to $1.1913. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":62050000,"source":{"system":"sec-edgar","filing":"0000919574-25-006597","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425006597/ownership.xml","form_type":"4"}},{"id":1002459,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":3,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":5,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":8,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-13T00:46:08.000Z","date":"2025-11-11","kind":"purchase","planned":false,"acquired":true,"shares":300000,"price":1.196,"value":358800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.1881 to $1.2053. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":61675000,"source":{"system":"sec-edgar","filing":"0000919574-25-006597","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425006597/ownership.xml","form_type":"4"}},{"id":1002458,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":3,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":5,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":8,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-13T00:46:08.000Z","date":"2025-11-10","kind":"purchase","planned":false,"acquired":true,"shares":275000,"price":1.1706,"value":321915.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.1688 to $1.1732. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":61375000,"source":{"system":"sec-edgar","filing":"0000919574-25-006597","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425006597/ownership.xml","form_type":"4"}},{"id":1002457,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":3,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":5,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":8,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-11-13T00:46:08.000Z","date":"2025-11-07","kind":"purchase","planned":false,"acquired":true,"shares":225000,"price":1.1234,"value":252765.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.1153 to $1.1321. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":61100000,"source":{"system":"sec-edgar","filing":"0000919574-25-006597","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425006597/ownership.xml","form_type":"4"}},{"id":1043114,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-09-12T01:03:04.000Z","date":"2025-09-09","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":1.2892,"value":128920.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2889 to $1.2895. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":60875000,"source":{"system":"sec-edgar","filing":"0000919574-25-005636","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425005636/ownership.xml","form_type":"4"}},{"id":1047009,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-09-05T23:08:45.000Z","date":"2025-09-04","kind":"purchase","planned":false,"acquired":true,"shares":250000,"price":1.2774,"value":319350.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2621 to $1.2930. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":60775000,"source":{"system":"sec-edgar","filing":"0000919574-25-005603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425005603/ownership.xml","form_type":"4"}},{"id":1047008,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-09-05T23:08:45.000Z","date":"2025-09-03","kind":"purchase","planned":false,"acquired":true,"shares":250000,"price":1.2656,"value":316400.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2414 to $1.2765. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":60525000,"source":{"system":"sec-edgar","filing":"0000919574-25-005603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425005603/ownership.xml","form_type":"4"}},{"id":1055985,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-08-27T00:46:24.000Z","date":"2025-08-26","kind":"purchase","planned":false,"acquired":true,"shares":125000,"price":1.2635,"value":157937.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":60275000,"source":{"system":"sec-edgar","filing":"0000919574-25-005152","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425005152/ownership.xml","form_type":"4"}},{"id":1055984,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-08-27T00:46:24.000Z","date":"2025-08-25","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":1.2409,"value":248180.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2311 to $1.2475. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":60150000,"source":{"system":"sec-edgar","filing":"0000919574-25-005152","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425005152/ownership.xml","form_type":"4"}},{"id":1055983,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":4,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":5,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":6,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":7,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":8,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-08-27T00:46:24.000Z","date":"2025-08-22","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":1.2634,"value":252680.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":59950000,"source":{"system":"sec-edgar","filing":"0000919574-25-005152","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425005152/ownership.xml","form_type":"4"}},{"id":1058521,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-08-22T21:46:20.000Z","date":"2025-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":54919,"price":1.27,"value":69747.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively."}],"balance_after":5681366,"source":{"system":"sec-edgar","filing":"0000950170-25-111052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025111052/ownership.xml","form_type":"4"}},{"id":1058520,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-08-22T21:45:36.000Z","date":"2025-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":19661,"price":1.27,"value":24969.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 3 and Form 4 filed with the U.S. Securities and Exchange Commission on September 3, 2024 and March 24, 2025, respectively."}],"balance_after":799496,"source":{"system":"sec-edgar","filing":"0001193125-25-186506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312525186506/ownership.xml","form_type":"4"}},{"id":1058716,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-22T21:45:22.000Z","date":"2025-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":12739,"price":1.27,"value":16178.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively."}],"balance_after":2427825,"source":{"system":"sec-edgar","filing":"0000950170-25-111050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000095017025111050/ownership.xml","form_type":"4"}},{"id":1065648,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":3,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":5,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":8,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-16T01:18:22.000Z","date":"2025-08-15","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":1.2214,"value":183210.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2179 to $1.2232. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":59750000,"source":{"system":"sec-edgar","filing":"0000919574-25-004979","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425004979/ownership.xml","form_type":"4"}},{"id":1065647,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":3,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":5,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":8,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-16T01:18:22.000Z","date":"2025-08-14","kind":"purchase","planned":false,"acquired":true,"shares":133220,"price":1.2126,"value":161542.572,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":59600000,"source":{"system":"sec-edgar","filing":"0000919574-25-004979","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425004979/ownership.xml","form_type":"4"}},{"id":1065646,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":3,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72209,"kind":"person","name":"Casdin Private Growth Equity Fund II, L.P.","position":5,"cik":"0001891102","reported_name":"Casdin Private Growth Equity Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72211,"kind":"person","name":"Casdin Private Growth Equity Fund II GP, LLC","position":6,"cik":"0001919480","reported_name":"Casdin Private Growth Equity Fund II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72212,"kind":"person","name":"Casdin Private Growth Equity Fund, L.P.","position":7,"cik":"0001823061","reported_name":"Casdin Private Growth Equity Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72210,"kind":"person","name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","position":8,"cik":"0001864554","reported_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-16T01:18:22.000Z","date":"2025-08-13","kind":"purchase","planned":false,"acquired":true,"shares":75000,"price":1.3104,"value":98280.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.3075 to $1.3118. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the \"GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":59466780,"source":{"system":"sec-edgar","filing":"0000919574-25-004979","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000091957425004979/ownership.xml","form_type":"4"}},{"id":1075444,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-05T22:33:03.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 40% of the RSUs on July 20, 2026, with the remaining 60% of the RSUs vesting on July 20, 2027, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 12,861 shares of common stock previously acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan."}],"balance_after":2440564,"source":{"system":"sec-edgar","filing":"0000950170-25-103300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000095017025103300/ownership.xml","form_type":"4"}},{"id":1075097,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-08-05T22:23:22.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 25% of the RSUs on August 1, 2026, with the remaining 75% of the RSUs vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares  previously acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan."}],"balance_after":5736285,"source":{"system":"sec-edgar","filing":"0000950170-25-103296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025103296/ownership.xml","form_type":"4"}},{"id":1102913,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-24T23:00:22.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":125660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":125660,"derivative":{"exercise_price":1.05,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":125660},"source":{"system":"sec-edgar","filing":"0000950170-25-089657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089657/ownership.xml","form_type":"4"}},{"id":1102912,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T23:00:22.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":94592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":256412,"source":{"system":"sec-edgar","filing":"0000950170-25-089657","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089657/ownership.xml","form_type":"4"}},{"id":1102911,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36079,"kind":"person","name":"ELOI FENEL M","position":1,"cik":"0001237190","reported_name":"ELOI FENEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-24T22:58:52.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":125660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":125660,"derivative":{"exercise_price":1.05,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":125660},"source":{"system":"sec-edgar","filing":"0000950170-25-089654","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089654/ownership.xml","form_type":"4"}},{"id":1102910,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36079,"kind":"person","name":"ELOI FENEL M","position":1,"cik":"0001237190","reported_name":"ELOI FENEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:58:52.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":94592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":236183,"source":{"system":"sec-edgar","filing":"0000950170-25-089654","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089654/ownership.xml","form_type":"4"}},{"id":1102909,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-24T22:58:06.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":188490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":188490,"derivative":{"exercise_price":1.05,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":188490},"source":{"system":"sec-edgar","filing":"0000950170-25-089653","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089653/ownership.xml","form_type":"4"}},{"id":1102908,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:58:06.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":94592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":194058,"source":{"system":"sec-edgar","filing":"0000950170-25-089653","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089653/ownership.xml","form_type":"4"}},{"id":1102907,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36006,"kind":"person","name":"Casdin Eli","position":1,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-24T22:57:24.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":125660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":125660,"derivative":{"exercise_price":1.05,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":125660},"source":{"system":"sec-edgar","filing":"0000950170-25-089651","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089651/ownership.xml","form_type":"4"}},{"id":1102906,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36006,"kind":"person","name":"Casdin Eli","position":1,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:57:24.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":94592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":2901062,"source":{"system":"sec-edgar","filing":"0000950170-25-089651","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089651/ownership.xml","form_type":"4"}},{"id":1102905,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":19440,"kind":"person","name":"HIBBS KATHY L","position":1,"cik":"0001267487","reported_name":"HIBBS KATHY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-24T22:55:15.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":125660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":125660,"derivative":{"exercise_price":1.05,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":125660},"source":{"system":"sec-edgar","filing":"0000950170-25-089644","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089644/ownership.xml","form_type":"4"}},{"id":1102904,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":19440,"kind":"person","name":"HIBBS KATHY L","position":1,"cik":"0001267487","reported_name":"HIBBS KATHY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:55:15.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":94592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":137720,"source":{"system":"sec-edgar","filing":"0000950170-25-089644","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089644/ownership.xml","form_type":"4"}},{"id":1102903,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-24T22:53:23.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":125660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":125660,"derivative":{"exercise_price":1.05,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":125660},"source":{"system":"sec-edgar","filing":"0000950170-25-089641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089641/ownership.xml","form_type":"4"}},{"id":1102902,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:53:23.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":94592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":210862,"source":{"system":"sec-edgar","filing":"0000950170-25-089641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089641/ownership.xml","form_type":"4"}},{"id":1129584,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-30T21:52:17.000Z","date":"2025-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":23919,"price":1.09,"value":26071.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 24, 2025."}],"balance_after":819157,"source":{"system":"sec-edgar","filing":"0000950170-25-079890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025079890/ownership.xml","form_type":"4"}},{"id":1129583,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-30T21:48:49.000Z","date":"2025-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":9906,"price":1.09,"value":10797.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 24, 2025."}],"balance_after":2731285,"source":{"system":"sec-edgar","filing":"0000950170-25-079886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025079886/ownership.xml","form_type":"4"}},{"id":1129800,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-30T21:48:23.000Z","date":"2025-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2583,"price":1.09,"value":2815.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 24, 2025."}],"balance_after":927703,"source":{"system":"sec-edgar","filing":"0000950170-25-079885","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000095017025079885/ownership.xml","form_type":"4"}},{"id":1132572,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-28T21:54:07.000Z","date":"2025-05-23","kind":"sale","planned":false,"acquired":false,"shares":1428,"price":0.941,"value":1343.748,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.92 to $0.9748 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":930286,"source":{"system":"sec-edgar","filing":"0000950170-25-078466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000095017025078466/ownership.xml","form_type":"4"}},{"id":1132266,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-28T21:52:31.000Z","date":"2025-05-23","kind":"sale","planned":false,"acquired":false,"shares":13217,"price":0.941,"value":12437.197,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.92 to $0.9748 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":843076,"source":{"system":"sec-edgar","filing":"0000950170-25-078463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025078463/ownership.xml","form_type":"4"}},{"id":1132265,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-28T21:44:58.000Z","date":"2025-05-23","kind":"sale","planned":false,"acquired":false,"shares":5473,"price":0.941,"value":5150.093,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.92 to $0.9748 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":2741191,"source":{"system":"sec-edgar","filing":"0000950170-25-078457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025078457/ownership.xml","form_type":"4"}},{"id":1134164,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-28T00:33:14.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":1355,"price":1.002,"value":1357.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9403 to $1.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":931714,"source":{"system":"sec-edgar","filing":"0000950170-25-078048","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000095017025078048/ownership.xml","form_type":"4"}},{"id":1133784,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-28T00:28:33.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":5116,"price":1.002,"value":5126.232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9403 to $1.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":2746664,"source":{"system":"sec-edgar","filing":"0000950170-25-078043","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025078043/ownership.xml","form_type":"4"}},{"id":1135742,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-23T22:13:16.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":12536,"price":1.002,"value":12561.072,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9403 to $1.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":856293,"source":{"system":"sec-edgar","filing":"0000950170-25-077191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025077191/ownership.xml","form_type":"4"}},{"id":1135741,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-23T22:13:16.000Z","date":"2025-05-21","kind":"sale","planned":false,"acquired":false,"shares":12838,"price":1.03,"value":13223.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $1.015 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":868829,"source":{"system":"sec-edgar","filing":"0000950170-25-077191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025077191/ownership.xml","form_type":"4"}},{"id":1137672,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-23T00:03:58.000Z","date":"2025-05-21","kind":"sale","planned":false,"acquired":false,"shares":4719,"price":1.03,"value":4860.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold to satisfy the tax withholding obligations that arose upon the vesting of RSUs granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the SEC on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $1.015 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":2751780,"source":{"system":"sec-edgar","filing":"0000950170-25-076591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025076591/ownership.xml","form_type":"4"}},{"id":1137671,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-23T00:03:58.000Z","date":"2025-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":18343,"price":1.05,"value":19260.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on May 21, 2024."}],"balance_after":2756499,"source":{"system":"sec-edgar","filing":"0000950170-25-076591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025076591/ownership.xml","form_type":"4"}},{"id":1138103,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-23T00:01:08.000Z","date":"2025-05-21","kind":"sale","planned":false,"acquired":false,"shares":1407,"price":1.03,"value":1449.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold to satisfy the tax obligations that arose upon the vesting of RSUs granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the SEC on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $1.015 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":933069,"source":{"system":"sec-edgar","filing":"0000950170-25-076590","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000095017025076590/ownership.xml","form_type":"4"}},{"id":1138102,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20554,"kind":"person","name":"Kim Hanjoon Alex","position":1,"cik":"0001919209","reported_name":"Kim Hanjoon Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-23T00:01:08.000Z","date":"2025-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":6364,"price":1.05,"value":6682.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on May 21, 2024."}],"balance_after":934476,"source":{"system":"sec-edgar","filing":"0000950170-25-076590","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919209/000095017025076590/ownership.xml","form_type":"4"}},{"id":1175841,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-04-08T20:04:11.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":false,"shares":196512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."}],"balance_after":196513,"derivative":{"underlying":"Common Stock","underlying_shares":196512},"source":{"system":"sec-edgar","filing":"0000950170-25-052047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025052047/ownership.xml","form_type":"4"}},{"id":1175840,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-04-08T20:04:11.000Z","date":"2025-04-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":57676,"price":1.07,"value":61713.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022."}],"balance_after":2774842,"source":{"system":"sec-edgar","filing":"0000950170-25-052047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025052047/ownership.xml","form_type":"4"}},{"id":1175839,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-04-08T20:04:11.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":true,"shares":196512,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2832518,"source":{"system":"sec-edgar","filing":"0000950170-25-052047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025052047/ownership.xml","form_type":"4"}}],"next_cursor":"2025-04-08T20:04:11.000000Z,1175839"}